By Ricardo Carvajal – Several Congressional representatives wrote a letter to FDA asking the agency to “fully implement” a provision of the FDCA that allows marketing as a dietary supplement of an article previously investigated for use as a drug. Section 201(ff)(3)(B)(ii) excludes from the definition …
Menu